RE:RE:RE:RE:CloudMD Undervalued relative to US PeersThats probably the case here. 2021 will be a transformational year for DOC and its shareholders.
After watching Dr Hamza's interview yesterday I believe that DOC has a totally unique value proposition for eneterprise in the form of a total suite of services.
It also seems the most recent acquisition in the US is not yet understood by the market and this deal by itself has propelled DOC to a new valuation level